Transthyretin Amyloidosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABUS | D | Arbutus Biopharma Corporation | 1.31 | |
NTLA | F | Intellia Therapeutics, Inc. | 2.41 |
Related Industries: Biotechnology
Related Stock Lists:
Amyloid
Amyloidosis
Hepatitis B
Hepatitis B Virus
Metabolism
Transthyretin
Acute Lymphoblastic Leukemia
Alcohol
Antitrypsin Deficiency
Biology
Biopharmaceutical
Biotechnology
CRISPR
Carcinoma
Cas9
Cell Product
Chimeric Antigen Receptor
Chimeric Antigen Receptor T Cell
Cholesterol
Cyclophilin
Related ETFs - A few ETFs which own one or more of the above listed Transthyretin Amyloidosis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARKG | D | ARK Genomic Revolution Multi-Sector ETF | 3.73 | |
GNOM | D | Global X Genomics & Biotechnology ETF | 3.05 | |
ARKK | D | ARK Innovation ETF | 2.43 | |
MOON | D | Direxion Moonshot Innovators ETF | 1.66 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.4 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Amyloid
Amyloidosis
Hepatitis B
Hepatitis B Virus
Metabolism
Transthyretin
Acute Lymphoblastic Leukemia
Alcohol
Antitrypsin Deficiency
Biology
Biopharmaceutical
Biotechnology
CRISPR
Carcinoma
Cas9
Cell Product
Chimeric Antigen Receptor
Chimeric Antigen Receptor T Cell
Cholesterol
Cyclophilin
- Transthyretin Amyloidosis
Transthyretin Amyloidosis (ATTR) is a rare, progressive, and fatal genetic disorder caused by the buildup of abnormal proteins in the body's organs and tissues. The abnormal proteins, called amyloid, are made up of a protein called transthyretin (TTR). As the amyloid builds up, it can damage organs and tissues, leading to a variety of symptoms. Symptoms of ATTR can include peripheral neuropathy, autonomic neuropathy, cardiomyopathy, and carpal tunnel syndrome. Treatment options for ATTR include medications, lifestyle changes, and organ transplantation.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles